Neurocrine Biosciences Inc (NBIX)
136.62
-2.95
(-2.11%)
USD |
NASDAQ |
May 10, 16:00
136.62
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Market Cap: 13.75B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 09, 2024 | 14.05B |
May 08, 2024 | 13.99B |
May 07, 2024 | 14.41B |
May 06, 2024 | 14.26B |
May 03, 2024 | 14.16B |
May 02, 2024 | 14.07B |
May 01, 2024 | 14.39B |
April 30, 2024 | 13.84B |
April 29, 2024 | 13.98B |
April 26, 2024 | 13.69B |
April 25, 2024 | 13.86B |
April 24, 2024 | 13.98B |
April 23, 2024 | 14.09B |
April 22, 2024 | 13.44B |
April 19, 2024 | 13.28B |
April 18, 2024 | 13.33B |
April 17, 2024 | 13.40B |
April 16, 2024 | 13.38B |
April 15, 2024 | 13.25B |
April 12, 2024 | 13.54B |
April 11, 2024 | 13.67B |
April 10, 2024 | 13.89B |
April 09, 2024 | 13.97B |
April 08, 2024 | 14.02B |
April 05, 2024 | 13.97B |
Date | Value |
---|---|
April 04, 2024 | 13.84B |
April 03, 2024 | 13.84B |
April 02, 2024 | 13.85B |
April 01, 2024 | 14.22B |
March 28, 2024 | 13.87B |
March 27, 2024 | 13.86B |
March 26, 2024 | 14.20B |
March 25, 2024 | 14.11B |
March 22, 2024 | 14.07B |
March 21, 2024 | 14.30B |
March 20, 2024 | 14.00B |
March 19, 2024 | 14.02B |
March 18, 2024 | 13.88B |
March 15, 2024 | 13.84B |
March 14, 2024 | 13.85B |
March 13, 2024 | 14.11B |
March 12, 2024 | 13.71B |
March 11, 2024 | 13.79B |
March 08, 2024 | 13.85B |
March 07, 2024 | 13.47B |
March 06, 2024 | 13.16B |
March 05, 2024 | 13.30B |
March 04, 2024 | 13.25B |
March 01, 2024 | 13.07B |
February 29, 2024 | 12.98B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.876B
Minimum
Jan 27 2022
14.41B
Maximum
May 07 2024
9.841B
Average
9.465B
Median
Mar 24 2023
Market Cap Benchmarks
Globus Medical Inc | 8.742B |
Inspire Medical Systems Inc | 4.986B |
AIM ImmunoTech Inc | 20.13M |
Protalix BioTherapeutics Inc | 81.09M |
Armata Pharmaceuticals Inc | 102.29M |
Market Cap Related Metrics
PE Ratio | 37.64 |
PS Ratio | 7.015 |
PEG Ratio | 0.0745 |
Price to Book Value | 5.762 |
Price to Free Cash Flow | 22.63 |
Price | 136.62 |
Earnings Yield | 2.66% |
PEGY Ratio | 0.0745 |
Operating PE Ratio | 29.56 |
Normalized PE Ratio | 46.30 |